TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Norovent AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
8,313
|
8,975
|
8,568 |
Financial expenses |
5
|
11
|
-1 |
Earnings before taxes |
582
|
574
|
799 |
Total assets |
3,217
|
3,106
|
2,862 |
Current assets |
2,116
|
1,881
|
1,834 |
Current liabilities |
1,250
|
1,869
|
1,866 |
Equity capital |
1,376
|
1,103
|
947 |
- share capital |
68
|
72
|
76 |
Employees (average) |
10
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
42.8%
|
35.5%
|
33.1% |
Turnover per employee |
898
|
714 | |
Profit as a percentage of turnover |
7.0%
|
6.4%
|
9.3% |
Return on assets (ROA) |
18.2%
|
18.8%
|
27.9% |
Current ratio |
169.3%
|
100.6%
|
98.3% |
Return on equity (ROE) |
42.3%
|
52.0%
|
84.4% |
Change turnover |
-110
|
857
|
-283 |
Change turnover % |
-1%
|
11%
|
-3% |
Chg. No. of employees |
-2
|
1 | |
Chg. No. of employees % |
-17%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.